| scholarly article | Q13442814 |
| P2093 | author name string | Rebecca Lee | |
| Ping Chen | |||
| James E Robinson | |||
| Benjamin K Chen | |||
| Natasha D Durham | |||
| Chati Zony | |||
| Alice W Yewdall | |||
| P2860 | cites work | HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse | Q22242967 |
| The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells | Q28139452 | ||
| Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
| Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC | Q28292719 | ||
| Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection | Q28369033 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. | Q30480956 | ||
| Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses | Q30480959 | ||
| Quantitative 3D video microscopy of HIV transfer across T cell virological synapses | Q30490761 | ||
| On the steps of cell-to-cell HIV transmission between CD4 T cells | Q30491261 | ||
| Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition | Q30493649 | ||
| Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion | Q30505286 | ||
| Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies | Q33614365 | ||
| Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody | Q33780450 | ||
| Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail | Q33984243 | ||
| Maturation-induced cloaking of neutralization epitopes on HIV-1 particles | Q34023008 | ||
| Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies | Q34229664 | ||
| A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 | Q34306804 | ||
| Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein | Q34332519 | ||
| The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. | Q34342352 | ||
| High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells | Q34550922 | ||
| Enhanced HIV-1 neutralization by antibody heteroligation | Q35735385 | ||
| HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores | Q35826780 | ||
| Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding | Q35845976 | ||
| Retroviral spread by induction of virological synapses | Q35856741 | ||
| Dangerous liaisons at the virological synapse | Q35877219 | ||
| Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. | Q36623941 | ||
| Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding | Q36649958 | ||
| Quantitation of human immunodeficiency virus type 1 infection kinetics | Q36686530 | ||
| Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody | Q36827670 | ||
| Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity | Q36944098 | ||
| Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? | Q37519312 | ||
| Toward an antibody-based HIV-1 vaccine | Q37613695 | ||
| Cell-to-Cell Spread of Retroviruses | Q37945208 | ||
| Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. | Q39438533 | ||
| A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. | Q39537121 | ||
| Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes | Q39705226 | ||
| Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. | Q40429324 | ||
| Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail | Q40579232 | ||
| Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains | Q40621073 | ||
| Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies | Q40682865 | ||
| A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. | Q40757568 | ||
| Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail | Q41898146 | ||
| A novel gene of HIV-1, vpu, and its 16-kilodalton product | Q42656133 | ||
| Inefficient human immunodeficiency virus replication in mobile lymphocytes | Q42957159 | ||
| Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells | Q58023483 | ||
| Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base | Q73149534 | ||
| P433 | issue | 14 | |
| P921 | main subject | virology | Q7215 |
| P304 | page(s) | 7484-7495 | |
| P577 | publication date | 2012-05-02 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail | |
| P478 | volume | 86 |
| Q30810565 | A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry |
| Q38811735 | Broadly neutralizing antibodies: An approach to control HIV-1 infection |
| Q35686912 | Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent |
| Q38154038 | Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies |
| Q38817990 | Dense Array of Spikes on HIV-1 Virion Particles |
| Q52689038 | Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion. |
| Q99557057 | Elucidating the basis for permissivity of the MT-4 T-cell line to replication of an HIV-1 mutant lacking the gp41 cytoplasmic tail |
| Q38376002 | HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy |
| Q41127118 | HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail |
| Q57030223 | HIV-1 cell-to-cell transmission and broadly neutralizing antibodies |
| Q40940285 | HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution |
| Q35897398 | HIV-1 vaginal transmission: cell-free or cell-associated virus? |
| Q30570557 | High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. |
| Q28535477 | Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone |
| Q38851814 | Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread |
| Q40852789 | Measuring T Cell-to-T Cell HIV-1 Transfer, Viral Fusion, and Infection Using Flow Cytometry. |
| Q38070789 | Mechanisms of enhanced HIV spread through T-cell virological synapses |
| Q59358562 | Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection |
| Q40312301 | New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif |
| Q47139556 | Non-Neutralizing Antibodies Directed against HIV and Their Functions |
| Q57285031 | P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model |
| Q34261784 | P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection |
| Q47548910 | Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage. |
| Q89592396 | Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation |
| Q39470792 | Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis |
| Q37425205 | Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells |
| Q49900491 | Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation. |
| Q38718435 | Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs |
| Q94569673 | Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein |
| Q59359981 | Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120 |
| Q36123960 | The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission |
| Q37415455 | The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. |
| Q38321444 | The cytoplasmic tail of retroviral envelope glycoproteins. |
| Q36940646 | The frantic play of the concealed HIV envelope cytoplasmic tail. |
| Q27002959 | The immunological synapse: the gateway to the HIV reservoir |
| Q36384607 | The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation. |
| Q40190061 | The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus |
| Q35529719 | Unique features of HIV-1 spread through T cell virological synapses |
| Q37635804 | Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41. |
| Q58591002 | Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones |
| Q41102793 | Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes |
| Q33772637 | Which Antibody Functions are Important for an HIV Vaccine? |
Search more.